[ad_1]
A closely watched survey of fund managers found that investors are becoming more cautious as the risk of a recession grows.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...